Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis-Related Key Genes in Cervical Squamous Cell Carcinoma

  • 0Department of Gynecology, Shanxi Medical University First Hospital, Taiyuan, China.

|

|

Summary

This summary is machine-generated.

This study identifies seven microRNAs (miRNAs) and three ferroptosis-related genes (SLC2A1, ANO6, TXNIP) as potential prognostic biomarkers for cervical squamous cell carcinoma, aiding in disease prediction and treatment strategies.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background

  • Cervical squamous cell carcinoma (CSCC) prognosis requires improved predictive markers.
  • MicroRNAs (miRNAs) and ferroptosis-related genes are implicated in cancer development and progression.
  • Understanding their role in CSCC can enhance patient stratification and therapeutic targeting.

Purpose Of The Study

  • To investigate the prognostic value of miRNAs and ferroptosis-related genes in CSCC.
  • To construct and validate predictive models for CSCC patient outcomes.
  • To explore the relationship between miRNA expression, risk scores, and the tumor microenvironment.

Main Methods

  • Data mining of public databases for differentially expressed miRNAs, ferroptosis-related genes, and clinical data.
  • Construction and validation of prognostic risk and nomogram models using survival and ROC analyses.
  • Bioinformatic analyses (KEGG, GO, GSEA) and experimental validation (qRT-PCR, western blotting) of key genes and miRNAs.

Main Results

  • Seven miRNA signatures (miR-100-3p, miR-301a-5p, miR-331-3p, miR-425-5p, miR-502-3p, miR-505-5p, miR-629-3p) were identified as prognostic markers.
  • Accurate prognostic risk and nomogram models were successfully constructed for CSCC.
  • Three key ferroptosis-related genes (SLC2A1, ANO6, TXNIP) were identified and validated, showing consistency with bioinformatics predictions.

Conclusions

  • The identified seven miRNAs show potential as prognostic biomarkers for cervical squamous cell carcinoma.
  • SLC2A1, ANO6, and TXNIP are associated with CSCC and may function as ferroptosis-related markers.
  • These findings contribute to improved prognostic assessment and potential therapeutic strategies for CSCC.